Kelly E Westbrook (Kelly Westbrook)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Randomized Controlled Trial

Metastatic Breast Cancer

Top Venues

Breast cancer research and treatment

JCO oncology practice

This page only lists publications with an associated author ORCID identifier.

Publications

Olivia White, Susan F Dent, Kelly E Westbrook, Hui-Jie Lee, Chengxin Yang, Heather B Moore
Assessment of efficacy and safety of dose-dense doxorubicin and cyclophosphamide (ddAC) in combination with immunotherapy in early-stage triple-negative breast cancer. Breast cancer research and treatment 207 (1) (2024)
Olivia White, Susan F Dent, Kelly E Westbrook, Hui-Jie Lee, Chengxin Yang, Heather B Moore
Assessment of efficacy and safety of dose-dense doxorubicin and cyclophosphamide (ddAC) in combination with immunotherapy in early-stage triple-negative breast cancer. Breast cancer research and treatment 207 (1) (2024)
Olivia White, Susan F Dent, Kelly E Westbrook, Hui-Jie Lee, Chengxin Yang, Heather B Moore
Assessment of efficacy and safety of dose-dense doxorubicin and cyclophosphamide (ddAC) in combination with immunotherapy in early-stage triple-negative breast cancer. Breast cancer research and treatment (2024)
Olivia White, Susan F Dent, Kelly E Westbrook, Hui-Jie Lee, Chengxin Yang, Heather B Moore
Assessment of efficacy and safety of dose-dense doxorubicin and cyclophosphamide (ddAC) in combination with immunotherapy in early-stage triple-negative breast cancer. Breast cancer research and treatment 207 (1) (2024)
Hope S Rugo, Christine L Crossno, Yaron B Gesthalter, Kristen Kelley, Heather B Moore, Mothaffar F Rimawi, Kelly E Westbrook, Saundra S Buys
Real-World Perspectives and Practices for Pneumonitis/Interstitial Lung Disease Associated With Trastuzumab Deruxtecan Use in Human Epidermal Growth Factor Receptor 2-Expressing Metastatic Breast Cancer. JCO oncology practice (2023)